Pathology Institute 2012

Subscriber Login

Login
G2IQ Logo
G2 Intelligence : market analysis for diagnostic testing laboratories (labs), pathology, and related medical services providers
LISO
Ezine Sign-up
FREE e-zine for diagnostics pros. Subscribe now to this weekly email featuring G2's proprietary findings.
Subscribe

Upcoming G2 Events

Pathology Institute 2012
February 9-10, 2012
The Westin Beach Resort & Spa
Fort Lauderdale, FL
Molecular Diagnostics – Spring
April 17-19, 2012
Fairmont Copley Plaza
Boston, MA

G2 Research

Diagnostics Market Analysis and Trends

Research

Lab Industry Strategic Outlook 2011: Market Trends & Analysis
Lab Industry Strategic Outlook 2011: Market Trends & Analysis
Lab Industry Analysis 2010: Test Volumes, Revenues, and Category Leaders Lab Industry Analysis 2010: Test Volumes, Revenues, and Category Leaders
U.S. Laboratory Reference Testing - Market Profile & Pricing Trends 2010
U.S. Laboratory Reference Testing - Market Profile & Pricing Trends 2010

Events

Molecular Diagnostics – Spring
April 17-19, 2012 - Boston, MA

Features & Analysis

»2011 a Mixed Year for Diagnostics Industry
The year 2011 was a tumultuous one for the diagnostics industry. Some companies were able to thrive with record revenue growth and an increasingly promising pipeline, while others saw revenues plummet and stock prices tumble under the pressure of global economic uncertainties.
more…
Copyright © 2012 Kennedy Information, LLC

Laboratory Business Strategy and Operations

Research

Value Driven Lab
Creating a Value-Driven Laboratory: Opportunities in the New Marketplace
How to Build an MDx Lab
How to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations
Healthcare Market Reforms
Health Care Market Reforms: Implications and Prescriptions for Laboratories
Sales Compensation in the Laboratory Industry: Incentives, Plans and Strategies
Sales Compensation in the Laboratory Industry: Incentives, Plans and Strategies

Events

Pathology Institute 2012
February 9-10, 2012 - Fort Lauderdale, FL

Features & Analysis

»FTC Approves LabCorp’s Acquisition of Orchid Cellmark But With Conditions
Following numerous extensions of its tender offer, LabCorp (Burlington, N.C.) in early December finally received approval from the Federal Trade Commission (FTC) to acquire Orchid Cellmark, but only under certain conditions.
more…
Copyright © 2012 Kennedy Information, LLC

Diagnostics Regulation, Compliance and Risk

Reference

2011 Medicare Reimbursement Manual for Laboratory & Pathology Services
2011 Medicare Reimbursement Manual for Laboratory & Pathology Services
CLIA Compliance: The Essential Reference for the Clinical Laboratory, 3rd Edition CLIA Compliance: The Essential Reference for the Clinical Laboratory, 3rd Edition

Features & Analysis

»Congress Defers Medicare Physician Pay Cut for Two Months; Last-Minute Deal Also Extends Pathology Grandfather Protection
In last-minute maneuverings, Congressional lawmakers Dec. 23 approved an amended version of payroll tax legislation that also would defer for two months a Medicare pay cut for physicians that had been due to be implemented Jan. 1.
more…
Copyright © 2012 Kennedy Information, LLC
LIR Sample

Lab and Pathology Free Newsletter
G2's FREE, weekly email gives you access to G2 market analysis, regulatory changes, M&A activity, leadership moves and more on the diagnostics industry. Recent articles include:

  • »Some Second Thoughts on Demise of Physician Signature Requirement
    Jim Curren, Editor, National Intelligence Report
    Welcome news it was for independent clinical labs and hospital labs serving nonhospital patients when the Centers for Medicare and Medicaid Services (CMS) expunged from the books the requirement for the signature of a physician or nonphysician practitioner (NPP) on paper test requisitions.
    more…
  • »BioReference Launches Solid Tumor Genotyping Test
    Kimberly Scott, Managing Editor, G2 Intelligence
    BioReference Laboratories Inc. (Elmwood Park, N.J.) and its GenPath Oncology business unit has launched a solid tumor genotype test called OnkoMatch, which it says is the first time this type of test has been available nationally.
    more…
  • »Looking to Dominate Sequencing Market, Roche Bids $5.7 Billion for Illumina
    Stephanie Murg, Managing Director, G2 Intelligence
    After failed attempts at a negotiated transaction, Roche has launched a $5.7 billion hostile takeover bid for Illumina.
    more…
More Insider Subscribe
Lab and Pathology Wire Logo

G2's FREE, daily email service brings you up-to-the-minute lab and diagnostics industry news from from across the spectrum of providers.
Subscribe
  • McKesson Tower Ad
Advertising | Privacy | Sitemap
G2 Intelligence © 2012 Kennedy Information, LLC
Phone: 800.401.5937 or +1.973.718.4700
All Rights Reserved.
|
»